210 MAIN STREET WEST, BAUDETTE, MN
Material disclosure
Investor Presentation
Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)
News, Articles of Incorporation
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Confidential Treatment Order
Submission Upload